Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CNTX-6970 for Knee Osteoarthritis Pain
NCT05025787Phase 2Completed
- Sponsor
- Maurizio Fava
- Start
- Oct 2021
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CNTX-6970 in knee osteoarthritis (OA), sponsored by Maurizio Fava. Started Oct 2021; status: completed.
02
Drugs
CNTX-6970
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT05025787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05025787.